|
Name |
Xenoacremone E
|
Molecular Formula | C29H33NO6 | |
IUPAC Name* |
4-ethenyl-5,19-dihydroxy-9,11-dimethyl-15,21-dioxa-23-azaheptacyclo[17.2.2.216,19.13,7.01,20.08,13.014,27]hexacosa-6,16(25),17,26-tetraene-2,22-dione
|
|
SMILES |
C=CC1C(O)C=C2C3CC(C)CC(C)C3C3Oc4ccc(cc4)CC4(O)NC(=O)C5(OC45)C(=O)C1C23
|
|
InChI |
InChI=1S/C29H33NO6/c1-4-17-20(31)11-19-18-10-13(2)9-14(3)21(18)24-22(19)23(17)25(32)29-26(36-29)28(34,30-27(29)33)12-15-5-7-16(35-24)8-6-15/h4-8,11,13-14,17-18,20-24,26,31,34H,1,9-10,12H2,2-3H3,(H,30,33)/t13-,14+,17-,18+,20-,21-,22+,23-,24-,26-,28-,29-/m1/s1
|
|
InChIKey |
ZZGLZMUCFNPITP-YENVCKQNSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 491.58 | ALogp: | 2.2 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 108.4 | Aromatic Rings: | 8 |
Heavy Atoms: | 36 | QED Weighted: | 0.317 |
Caco-2 Permeability: | -4.977 | MDCK Permeability: | 0.00008560 |
Pgp-inhibitor: | 0.047 | Pgp-substrate: | 0.026 |
Human Intestinal Absorption (HIA): | 0.417 | 20% Bioavailability (F20%): | 0.071 |
30% Bioavailability (F30%): | 0.05 |
Blood-Brain-Barrier Penetration (BBB): | 0.176 | Plasma Protein Binding (PPB): | 96.27% |
Volume Distribution (VD): | 2.486 | Fu: | 3.68% |
CYP1A2-inhibitor: | 0.015 | CYP1A2-substrate: | 0.757 |
CYP2C19-inhibitor: | 0.134 | CYP2C19-substrate: | 0.893 |
CYP2C9-inhibitor: | 0.086 | CYP2C9-substrate: | 0.06 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.261 |
CYP3A4-inhibitor: | 0.904 | CYP3A4-substrate: | 0.9 |
Clearance (CL): | 9.918 | Half-life (T1/2): | 0.023 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.337 |
Drug-inuced Liver Injury (DILI): | 0.959 | AMES Toxicity: | 0.136 |
Rat Oral Acute Toxicity: | 0.996 | Maximum Recommended Daily Dose: | 0.897 |
Skin Sensitization: | 0.024 | Carcinogencity: | 0.493 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.94 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005135 | 0.681 | D0VA0I | 0.229 | ||||
ENC005366 | 0.570 | D0W2EK | 0.211 | ||||
ENC003606 | 0.570 | D06OMK | 0.208 | ||||
ENC003989 | 0.561 | D01XDL | 0.206 | ||||
ENC005768 | 0.522 | D0H0SJ | 0.204 | ||||
ENC005766 | 0.493 | D0Z4UN | 0.199 | ||||
ENC005769 | 0.492 | D06WTZ | 0.199 | ||||
ENC005770 | 0.492 | D0H0ND | 0.196 | ||||
ENC003349 | 0.467 | D01XWG | 0.193 | ||||
ENC003137 | 0.457 | D0V3ZA | 0.191 |